Granted Patent
Utility
US 6,743,441 · App. 10/098,752
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Inventors:
Steven Sanders, Charles D. Ebert
Patented Case
View Patent ↗
Granted: Jun 1, 2004
Filed: Mar 15, 2002
Inventors
Steven Sanders
Charles D. Ebert
Assignee (at issue)
Watson Pharmaceuticals, Inc.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.